Literature DB >> 23993918

Chemistry-enabled drug delivery (prodrugs): recent progress and challenges.

Sophie-Dorothee Clas1, Rosa I Sanchez2, Rebecca Nofsinger3.   

Abstract

Prodrugs can be used to enhance the properties of an active pharmaceutical ingredient or drug, generally by improving solubility and/or permeability of the compound. However, discovery teams duly spend considerable time and resources on structure-activity optimization and formulation-enabled drug delivery technologies to achieve the target exposures and biopharmaceutical properties, when early implementation of prodrugs could lead to an improved drug molecule. The goal of this review is to provide an overview of the achievements during the past few years in developing prodrugs and highlighting the challenges of following this approach.
Copyright © 2013 Elsevier Ltd. All rights reserved.

Mesh:

Substances:

Year:  2013        PMID: 23993918     DOI: 10.1016/j.drudis.2013.08.014

Source DB:  PubMed          Journal:  Drug Discov Today        ISSN: 1359-6446            Impact factor:   7.851


  15 in total

1.  Multicolor imaging of endoplasmic reticulum-located esterase as a prodrug activation enzyme.

Authors:  Wataru Hakamata; Saori Tamura; Takako Hirano; Toshiyuki Nishio
Journal:  ACS Med Chem Lett       Date:  2014-01-16       Impact factor: 4.345

2.  Synthesis of a long acting nanoformulated emtricitabine ProTide.

Authors:  Dhruvkumar Soni; Aditya N Bade; Nagsen Gautam; Jonathan Herskovitz; Ibrahim M Ibrahim; Nathan Smith; Melinda S Wojtkiewicz; Bhagya Laxmi Dyavar Shetty; Yazen Alnouti; JoEllyn McMillan; Howard E Gendelman; Benson J Edagwa
Journal:  Biomaterials       Date:  2019-08-20       Impact factor: 12.479

Review 3.  The expanding role of prodrugs in contemporary drug design and development.

Authors:  Jarkko Rautio; Nicholas A Meanwell; Li Di; Michael J Hageman
Journal:  Nat Rev Drug Discov       Date:  2018-04-27       Impact factor: 84.694

Review 4.  Self-assembling prodrugs.

Authors:  Andrew G Cheetham; Rami W Chakroun; Wang Ma; Honggang Cui
Journal:  Chem Soc Rev       Date:  2017-10-30       Impact factor: 54.564

Review 5.  Microbial esterases and ester prodrugs: An unlikely marriage for combating antibiotic resistance.

Authors:  Erik M Larsen; R Jeremy Johnson
Journal:  Drug Dev Res       Date:  2018-10-10       Impact factor: 4.360

Review 6.  Toxicity mechanism-based prodrugs: glutathione-dependent bioactivation as a strategy for anticancer prodrug design.

Authors:  Xin-Yu Zhang; Adnan A Elfarra
Journal:  Expert Opin Drug Discov       Date:  2018-08-13       Impact factor: 6.098

7.  Design of prodrugs to enhance colonic absorption by increasing lipophilicity and blocking ionization.

Authors:  Rebecca Nofsinger; Sophie-Dorothee Clas; Rosa I Sanchez; Abbas Walji; Kimberly Manser; Becky Nissley; Jaume Balsells; Amrithraj Nair; Qun Dang; David Jonathan Bennett; Michael Hafey; Junying Wang; John Higgins; Allen Templeton; Paul Coleman; Jay Grobler; Ronald Smith; Yunhui Wu
Journal:  Pharmaceuticals (Basel)       Date:  2014-02-24

8.  Synthesis of a highly water-soluble acacetin prodrug for treating experimental atrial fibrillation in beagle dogs.

Authors:  Hui Liu; Ya-Jing Wang; Lei Yang; Mei Zhou; Man-Wen Jin; Guo-Sheng Xiao; Yan Wang; Hai-Ying Sun; Gui-Rong Li
Journal:  Sci Rep       Date:  2016-05-10       Impact factor: 4.379

9.  Creation of a long-acting nanoformulated dolutegravir.

Authors:  Brady Sillman; Aditya N Bade; Prasanta K Dash; Biju Bhargavan; Ted Kocher; Saumi Mathews; Hang Su; Georgette D Kanmogne; Larisa Y Poluektova; Santhi Gorantla; JoEllyn McMillan; Nagsen Gautam; Yazen Alnouti; Benson Edagwa; Howard E Gendelman
Journal:  Nat Commun       Date:  2018-02-06       Impact factor: 14.919

10.  Prodrugs for colon-restricted delivery: Design, synthesis, and in vivo evaluation of colony stimulating factor 1 receptor (CSF1R) inhibitors.

Authors:  Dawn M George; Raymond J Huntley; Kevin Cusack; David B Duignan; Michael Hoemann; Jacqueline Loud; Regina Mario; Terry Melim; Kelly Mullen; Gagandeep Somal; Lu Wang; Jeremy J Edmunds
Journal:  PLoS One       Date:  2018-09-07       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.